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Comparison of Clinical and Histopathologic Findings of
Pathergy Test with Disposable/Sharp and
Nondisposable/Blunt Needles in Behçet’s Disease
Aim: The aim of this study was to determine whether using blunt instead of sharp needles presented any
advantage and whether the histopathological interpretation prevailed over the clinical interpretation.
Materials and Methods: This study was performed on 60 Behçet’s disease (BD) patients and 20 control
subjects. The pathergy test was applied to all subjects intradermally with sharp and blunt needles and the
histopathology of each test result was studied.
Results: In the active period of BD (40 patients), positive test results were obtained in 34 (85.0%) patients
using blunt needles and in 13 (32.5%) using sharp needles (P = 0.0001). In the active group, there was a
significant difference in results when compared with the histopathologic findings (P < 0.05). In the remission
period group (20 patients), positive results were obtained in 9 (45.0%) patients with blunt needles and in 2
(10.0%) with sharp needles (P = 0.013). In the remission group, there were no significant differences in
results when compared with the histopathologic findings. In the control group patients, all blunt and sharp
needle pathergy tests were negative.
Conclusions: This study has demonstrated that a higher positivity rate is obtained in pathergy tests using
blunt needles when compared with sharp needles. We suggest that clinical interpretation of the pathergy test
with blunt needles is adequate to determine activity of BD; histopathologic interpretation does not provide any
extra advantages.
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Behçet Hastalarında Künt ve Sivri Uçlu İğnelerle Yapılan Paterji Testinin Klinik
ve Histopatolojik Bulgularının Karşılaştırılması
Amaç: Bu çalışmanın amacı künt uçlu iğnelerle yapılan uygulamanın sivri uçlu iğnelerle yapılana ve
histopatolojik değerlendirmenin klinik değerlendirmeye bir üstünlük sağlayıp sağlamadığını değerlendirmektir.
Yöntem ve Gereç: Çalışmaya 60 Behçet hastası ve 20 kontrol grubu hastası alındı. Paterji testi tüm hastalara
künt ve sivri uçlu iğnelerle intradermal olarak uygulandı ve test sonuçları histopatolojik olarak değerlendirildi.
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Bulgular: Aktif dönemdeki 40 Behçet hastasından künt uçlu iğne uygulanan hastaların 34’ünde (% 85) ve
sivri uçlu iğne uygulanan hastaların 13’ünde (% 32.5) pozitiflik saptandı (p=0.0001). Aktif dönemde
histopatolojik bulgular arasında da belirgin farklılıklar vardı (P < 0.05). Remisyon dönemindeki grupta (20
hasta) künt uçlu iğne uygulanan 9 (% 45) ve sivri uçlu iğne uygulanan 2 (% 10) hastada pozitif sonuç alındı
(P = 0.013). Remisyon grubunda histopatolojik bulgulardaki farklılıklar istatistiksel olarak anlamlı değildi.
Kontrol grubunda hem künt, hem de sivri uçlu iğnelerle yapılan paterji testi sonuçları negatifti.
Sonuç: Bu çalışmada künt uçlu iğnelerin kullanılmasıyla sivri uçlu iğnelere göre daha yüksek oranda pozitiflik
elde edildiği görülmüştür. Künt uçlu iğnelerle uygulanan paterji testinin klinik olarak değerlendirilmesinin
Behçet hastalığı aktivitesini değerlendirmede yeterli olduğunu ve histopatolojik değerlendirmenin ekstra bir
avantaj sağlamadığını düşünmekteyiz.
Anahtar Sözcükler: Behçet hastalığı, künt uçlu iğne, histopatolojik değerlendirme, paterji testi, sivri uçlu iğne

drayserem@yahoo.com

47

KARADAĞ, A S et al.

Pathergy Test with Sharp & Blunt Needles in Behçet’s Disease

Introduction
Behçet’s disease (BD) is a type of vasculitis with
unknown etiology that can affect multiple systems of the
human body (1,2). Unfortunately, there is no specific
laboratory test to diagnose BD. All the criteria for BD
recognized by the International BD Study Group are
based on clinical signs and symptoms, except for the
pathergy test (PT) (3). Recently, questions have arisen
regarding the positivity of PT in the diagnosis of BD (4).
It has been considered that the thickness of the needle
affects PT positivity, and also that the histopathologic
examination of the skin lesion that occurs after PT can be
useful in confirming BD diagnosis (5,6).
We designed this prospective study to determine
whether using nondisposable/blunt needles instead of
disposable/sharp needles presented any advantage and
whether the histopathologic interpretation prevailed over
the clinical interpretation. Secondly, we aimed to
ascertain if the PT could be a criterion in determining
disease activity.
Materials and Methods
The PT was performed in 60 BD patients (27 M, 33
F) who were diagnosed with BD according to the
International BD Study Group criteria (3). Twenty
patients with dermatoses (11 F, 9 M) were selected to
serve as the control group. The average age of the BD
patients was 33.50 ± 9.64 years and of the control
group was 30.50 ± 14.89 years. All subjects were
informed about the procedure and provided written
informed consents.
The patients in the study group with one or more
clinical symptoms were assigned to the active period group
(n: 40), and patients with prior diagnosis of BD but without
any recent symptoms or signs were assigned to the
remission period group (n: 20). The patient and control
groups did not take immunosuppressant drugs, steroids,
colchicine or non-steroidal anti-inflammatory drugs
(NSAIDs) for at least one month before the test. In the
control group, patients with any history of clinical
symptoms similar to BD, any history of positive PT diseases
such as pyoderma gangrenosum, erythema elevatum
diutinum and inflammatory bowel diseases were excluded.
Pathergy test was performed with disposable/sharp
and nondisposable/blunt needles in all patients.
Nondisposable/blunt and disposable/sharp needles of type
20 G = No.1 were used in the tests. Hairless and avascular
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regions in the flexor part of both forearms were chosen
to perform PT. Skin was cleaned with alcohol before the
test. PT was done with nondisposable/blunt needles on the
right forearm and with disposable/sharp needles on the
left forearm. The test was applied intradermally for each
type of needle without any rotational movements and was
evaluated clinically after 24 and 48 hours (h). The
occurrence of erythema without any indurations was
considered as ‘negative’ and the occurrence of papules and
pustules was considered as ‘positive’. For histopathologic
examination, biopsy at the intradermal puncture site was
taken after 48 h.
The statistical analysis was carried out using SPSS
(Statistical Package for Social Sciences) 10.0 for
Windows. The Pearson chi-square test and continuity
correction test were used for statistical analysis. P values
less than 0.05 were defined as statistically significant.
Results
Clinical Results
Among the 40 patients in the active period of BD,
positive PT results were obtained in 34 patients (85.0%)
using nondisposable/blunt needles and in 13 patients
(32.5%) using disposable/sharp needles, and the
difference between the two groups was statistically
significant (P = 0.0001).
Among the 20 patients in the remission period group,
positive PT results were obtained in 9 patients (45.0%)
using nondisposable/blunt needles and in 2 patients
(10.0%) using disposable/sharp needles, and the
difference between the two groups was statistically
significant (P = 0.013).
When active and remission periods were compared,
PT positivity with nondisposable/blunt needle was found
to be statistically higher in active period patients (P =
0.001). PT positivity with disposable/sharp needle was
higher in the active period, but the difference was not
statistically significant (P = 0.058). PT positivity results
with nondisposable/blunt and disposable/sharp needles in
the BD patients are shown in Table 1.
In the control group patients, the results of PT with
both nondisposable/blunt and disposable/sharp needle
were negative. Difference in PT positivity with
nondisposable/blunt and disposable/sharp needle in both
the active and remission period groups was statistically
significant when compared with the control group (P =
0.001, P = 0.002; P = 0.001, P = 0.04, respectively).
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Table 1. Comparison of pathergy test results with nondisposable/blunt and disposable/sharp
needles in the active and remission periods.
Nondisposable/blunt needle

Active period (%)
Remission period (%)

Disposable/sharp needle

Positive

Negative

Positive

Negative

34 (85.0)

6 (15)

13 (32.5)

27 (67.5)

9 (45)

11 (55)

2 (10)

18 (90)

Histopathologic Results
Table 2 gives the histopathologic results of the PT in
the patient and control groups. When positive and
negative PT results with nondisposable/blunt needle and
disposable/sharp needle were compared in the active
period patients, the presence of perivascular lymphocytic
infiltration, thickening of blood vessel walls, and
extravasations of erythrocytes, and the coexistence of
these three symptoms, which indicate blood vessel
damage, were found statistically significantly more
common in patients with positive PT using
nondisposable/blunt needle than in patients with negative
PT using nondisposable/blunt needle (P < 0.05, P < 0.05,
P < 0.05 and P < 0.05, respectively). They were also
found statistically significantly more common in patients
with disposable/sharp needle positive PT than in patients
with disposable/sharp needle negative PT (P < 0.05, P <
0.05, P < 0.05 and P < 0.05, respectively).
When PT results with nondisposable/blunt needle and
disposable/sharp needle were compared in active period
patients, the coexistence of perivascular lymphocytic
infiltration, thickening of blood vessel walls, and
extravasations of erythrocytes was found statistically
significantly more common using nondisposable/blunt
needle than disposable/sharp needle (P = 0.044).
Lymphocytic vasculitis was observed in 2 of the
positive PT patients with nondisposable/blunt needles
(7.4%), whereas no lymphocytic vasculitis was
determined in the negative PT patients with
nondisposable/blunt needles. In addition, neutrophilic
infiltration was seen in 10 of the positive PT patients with
nondisposable/blunt needles (29.4%), but in only 2 of the
negative PT patients with nondisposable/blunt needles
(33.3%).
Comparisons of the positive and negative test results
with nondisposable/blunt needles and disposable/sharp

needles in the remission period patients revealed no
statistically significant differences. Comparisons of the
histopathologic findings between nondisposable/blunt and
disposable/sharp needles in the remission period patients
also revealed no statistically significant differences.
Comparison of histopathologic findings of PT using
nondisposable/blunt needles in the active and remission
period patients, ignoring the results of the clinical
interpretation of PT, revealed that the occurrence of
edema in the upper layer of the dermis, perivascular
neutrophilic infiltration, periadnexal neutrophilic
infiltration, erythrocyte extravasations, neutrophilic
leukocyte infiltration located in the dermis, neutrophilic
vascular reaction, lymphocyte infiltration in fat tissue, and
lymphocyte exocytosis in the epidermis was also
statistically significantly higher in the active period than in
the remission period (P = 0.001, P < 0.005, P < 0.005,
P < 0.005, P = 0.004, P = 0.001, P = 0.0019, P =
0.037, respectively).

Discussion
Pathergy test is the nonspecific hyperactivity of the
skin. Positive PT is the one of the important diagnostic
criteria for BD; however, the incidence of PT positivity
has declined in recent years. In the literature, the rate of
positive PT in Turkey was shown as approximately 80%
before 1984; however, the positivity rate decreased after
1986 (1,7). Studies have shown that the sharpness of the
needle has a significant role in the positivity rate of PT
(4,5,8). The wide use of the blunt and nondisposable
needle before 1986 might be a reason for the high
positivity rate of PT. After 1986, sterile and disposable
needles began to be used routinely to avoid spread of
infectious diseases, such as human immunodeficiency
virus (HIV) and hepatitis B virus (HBV). The same
situation is true for other developing countries. The
49
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Table 2. Histopathologic findings in the Behçet’s disease and control groups.
Patient/Control
Needle

Active period
ND/B
+

Remission period

ND/B
–

D/S
+

D/S
–

ND/B
+

ND/B
–

Control group

D/S
+

D/S
–

ND/B
+

ND/B
–

D/S
+

D/S
–
20

n

34

6

13

27

9

11

2

18

0

20

0

EdE

11

0

5

2

3

0

1

0

0

0

0

0

Lpyi

34

6

13

22

10

8

2

15

0

19

0

13

Npvi

31

4

4

12

5

3

2

3

0

1

0

0

Lpai

24

2

6

4

8

1

2

1

0

1

0

1

Npai

14

2

1

0

6

1

1

1

0

0

0

1

BVT

17

1

4

2

5

1

1

2

0

7

0

2

EE

16

1

5

3

2

0

0

4

0

1

0

0

AE

3

0

1

0

1

0

0

0

0

0

0

0

DBL

16

4

3

1

3

2

1

3

0

6

0

3

Nİ

21

3

3

3

5

1

2

1

0

5

0

2

V

2

0

0

0

1

0

0

0

0

0

0

0

NVR

10

2

1

1

1

0

0

0

0

0

0

0

LIFT

10

0

1

0

3

1

1

0

0

0

0

0

ExE

10

0

6

3

3

0

0

1

0

1

0

0

ND/B: nondisposable/blunt; D/S: disposable/sharp; EdE: edema on epidermis; Lpvi: lymphohistiocytic perivascular infiltration; Npvi:
neutrophilic perivascular infiltration; Lpai: lymphohistiocytic periadnexal infiltration; Npai: neutrophilic periadnexal infiltration; BVT:
blood vessel thickening; EE: erythrocyte extravasation; AE: acanthosis in the epidermis; DBL: degeneration in basal layer; NI:
neutrophilic infiltration; V: vasculitis; NVR: neutrophilic vascular reaction; LIFT: lymphohistiocytic infiltration in fat tissue; ExE:
exocytosis in epidermis; n: number of patients.

reason for the low positivity rate of PT in developed
countries might be due to the use of sterile and
disposable needles for years (4,8,9).
When the needle reaches the dermis, a pathergy
reaction occurs. Dilsen et al. (4) and Akmaz et al. (5)
compared the nondisposable/blunt and disposable/sharp
needles in BH patients and showed more positive PT
results with nondisposable/blunt needles. Dilsen et al. (4)
suggested that calcium deposit accumulation at the tip of
nondisposable/blunt needles occurred when they were
sterilized in boiling water, and that they therefore
became more traumatic than disposable/sharp needles.
The results of the test depend on the sharpness, type,
sterility, and size of the needle, number of pricks, and
disease activity (7). The most important factor that
affects PT results is the thickness of the needle. There is
no standard for measurement of needle thickness. The
most important aim in the PT is to cause trauma to
provoke neutrophilic vascular reaction or leukocytoclastic
50

vasculitis. A thin needle may not be sufficient to induce
reaction (4,5). Ozarmagan et al. (8) compared 20G and
26G disposable needles, and they found 65% positive
results with 20G needles and 35% positive results with
26G needles. Dilsen et al. (4) compared needles of
different thicknesses, and they demonstrated more
positive results with 20G needles than wih 26G needles.
For this reason, we used 20 G needles for the tests in our
study group of patients.
Pathergy test gives more positive results in the active
period than remission period (5,9). In Akmaz et al.’s (5)
study, PT with nondisposable/blunt needles was positive
in 81.3% in the active period and in 45.5% in the
remission period. PT with disposable/sharp needles gave
18.8% positive results in the active period, but no
positive results were obtained in the remission period.
Friedman-Birnbaum and colleagues (9) found 45 positive
results in 46 patients in the active period. In our analysis,
the positivity rate with nondisposable/blunt needles was

Vol: 39

No: 1

Pathergy Test with Sharp & Blunt Needles in Behçet’s Disease

found statistically higher than with disposable/sharp
needles and overall positivity rate with both needles was
statistically significant higher in the active period.
Therefore, in light of our encouraging results, we
advocate using PT as an activity criterion in BD.
The clinical use of PT is very important in the
diagnosis of BD. On the other hand, misinterpretation of
the test might cause false-positive or false-negative
results. For that reason, immunopathologic and
histopathologic tests are recommended with PT (10). The
histopathologic results of PT depend on the time of the
biopsy (10,11). In the first 6 h, polymorphonuclear
leukocytes (PMNLs) are dominant in inflammatory
exudate. After 24 h, mononuclear cell infiltration in
dermal vessels, edema in vessel endothelium, and edema
and leukocytoclasia in reticular dermis are seen (10,11).
Leukocytoclastic vasculitis and neutrophilic vascular
reactions also occur after 24 h. Lymphocytic vasculitis and
lymphocytic perivascular infiltrations are found later (1215). In this study, all biopsies were taken after 48 h for
confident comparisons. In histopathology of the PT, the
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presence of the vasculitis and neutrophilic vascular
reaction are definitive but not a requirement. The
perivascular and periadnexal lymphohistiocytic infiltration
of varying intensity and their penetration in the deep
dermis and moderate neutrophilic infiltration in the
dermis are also important findings (12). In this study,
lymphohistiocytic infiltration, blood vessel wall
thickening, and erythrocyte extravasation were found
statistically higher in positive PT in both
nondisposable/blunt and disposable/sharp needle groups
in the active period. This result was consistent with
Akmaz et al.’s (5) studies. When the same histopathologic
comparisons were done for the remission period, no
statistically significant difference was observed.
Overall, we have shown a significant correlation
between BD activity and PT with nondisposable/blunt
needle. We could not identify any additional impact of
histopathological interventions in this regard.
Consequently, we believe that histopathological analysis
would be more helpful in the diagnosis of clinically
negative PT cases.
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